The original anticonvulsant meta-Cl-benzhydrylurea (m-CL-BHM) induces of the liver monooxygenase system and stimulates the neuroimmune response in behavioral disorders of alcoholic origin. (1st June 2022)
- Record Type:
- Journal Article
- Title:
- The original anticonvulsant meta-Cl-benzhydrylurea (m-CL-BHM) induces of the liver monooxygenase system and stimulates the neuroimmune response in behavioral disorders of alcoholic origin. (1st June 2022)
- Main Title:
- The original anticonvulsant meta-Cl-benzhydrylurea (m-CL-BHM) induces of the liver monooxygenase system and stimulates the neuroimmune response in behavioral disorders of alcoholic origin
- Authors:
- Shushpanova, Т.
Novozheeva, T.
Gutkevich, E.
Pustovaya, A.
Garganeeva, N.
Belousov, M.
Podyablonsky, A.
Markova, E.
Knyazeva, E.
Shushpanova, O.
Kolomiets, N.
Safronov, S.
Boev, R. - Abstract:
- Abstract : Introduction: The anticonvulsant m-Cl-BHM is promising for the pathogenetically directed thrapy does not cause negative effects. Objectives: Investigation of the effect of m-Сl-BHM on "immunochemical homeostasis" in rats with experimental alcoholism. Methods: m-Cl-BHM was injected at a dose of 100 mg/kg (1/20 LD50) for 5 and 30 days into the stomach of male Wistar rats who preferred alcohol according to the screening conditions and kept for 10 months. in free access to a 15% ethanol solution, which made up the group of "heavy drinkers" (HD). Phenobarbital was administered at a dose of 25 mg/kg (1/20 LD50). Results: The features of the monooxygenase system of cytochrome P450 of the liver and ECT in the lymphoid organs of rats were studied at different periods of administration of m-CL-BHM -5 and 30 days. to HD rats. m-CL-BHM has an inducing effect on the monooxygenase system of the liver, causes phase changes in the lymphoid organs and ECT. Long-term administration of m-CL-BHM caused a depletion of the cellular composition of lymphoid organs, a decrease in ECT of spleen cells and peritoneal exudate, these changes were less pronounced compared with phenobarbital. The activation of the immune system inversely regulates the production of enzymes of the cytochrome system, since the concentration of low molecular weight targets is sharply reduced with the help of antibodies. m-Cl-BHM metabolites conjugated to endogenous macromolecules form a full-fledged stimulus forAbstract : Introduction: The anticonvulsant m-Cl-BHM is promising for the pathogenetically directed thrapy does not cause negative effects. Objectives: Investigation of the effect of m-Сl-BHM on "immunochemical homeostasis" in rats with experimental alcoholism. Methods: m-Cl-BHM was injected at a dose of 100 mg/kg (1/20 LD50) for 5 and 30 days into the stomach of male Wistar rats who preferred alcohol according to the screening conditions and kept for 10 months. in free access to a 15% ethanol solution, which made up the group of "heavy drinkers" (HD). Phenobarbital was administered at a dose of 25 mg/kg (1/20 LD50). Results: The features of the monooxygenase system of cytochrome P450 of the liver and ECT in the lymphoid organs of rats were studied at different periods of administration of m-CL-BHM -5 and 30 days. to HD rats. m-CL-BHM has an inducing effect on the monooxygenase system of the liver, causes phase changes in the lymphoid organs and ECT. Long-term administration of m-CL-BHM caused a depletion of the cellular composition of lymphoid organs, a decrease in ECT of spleen cells and peritoneal exudate, these changes were less pronounced compared with phenobarbital. The activation of the immune system inversely regulates the production of enzymes of the cytochrome system, since the concentration of low molecular weight targets is sharply reduced with the help of antibodies. m-Cl-BHM metabolites conjugated to endogenous macromolecules form a full-fledged stimulus for the immune system. Conclusions: Neuroimmune response to the introduction of m-CL-BHM is significant in behavioral disorders associated with alcoholism and the correction of this condition. Disclosure: No significant relationships. … (more)
- Is Part Of:
- European psychiatry. Volume 65:Supplement 1(2022)
- Journal:
- European psychiatry
- Issue:
- Volume 65:Supplement 1(2022)
- Issue Display:
- Volume 65, Issue 1 (2022)
- Year:
- 2022
- Volume:
- 65
- Issue:
- 1
- Issue Sort Value:
- 2022-0065-0001-0000
- Page Start:
- S819
- Page End:
- S820
- Publication Date:
- 2022-06-01
- Subjects:
- anticonvulsant -- cytochrome -- receptor -- homeostasis -- immune function
Psychiatry -- Periodicals
Mental illness -- Periodicals
Electronic journals
616.89 - Journal URLs:
- https://www.cambridge.org/core/journals/european-psychiatry ↗
http://www.clinicalkey.com/dura/browse/journalIssue/09249338 ↗
http://www.sciencedirect.com/science/journal/09249338 ↗
http://www.elsevier.com/homepage/elecserv.htt ↗ - DOI:
- 10.1192/j.eurpsy.2022.2120 ↗
- Languages:
- English
- ISSNs:
- 0924-9338
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3829.842700
British Library HMNTS - ELD Digital store - Ingest File:
- 23311.xml